Kardigan Launches with Industry-Leading Team - citybiz.co

Jan 10, 2025 · Combining its leading-edge discovery and translational research platform with strategic in-licensing and acquisitions, Kardigan is building a fully integrated biopharmaceutical …

CouponFollow Extension

$300
OFF

Kardigan Launches With $300 Million Series A To Transform ...

2 weeks from now

Jan 13, 2025 · Combining its leading-edge discovery and translational research platform with strategic in-licensing and acquisitions, Kardigan is building a fully integrated biopharmaceutical …

biopharmaboardroom.com

$300
OFF

Kardigan Launches With Cozy $300M, Late-stage Portfolio

2 weeks from now

Jan 10, 2025 · A new company is making its debut with a series A sum that’s sure to make hearts race. Launching with $300 million in hand, Kardigan plans to develop parallel treatments to …

fiercebiotech.com

$300
OFF

Kardigan Debuts With $300M And Visionary Team To Revolutionize ...

2 weeks from now

San Francisco & Princeton, NJ, January 10, 2025 (Business Wire) -- Kardigan launches with $300 million in funding and a mission to cure and prevent cardiovascular disease, led by Tassos …

jacobsmgt.com

$300
OFF

Kardigan On LinkedIn: Kardigan Launches With Industry-Leading …

2 weeks from now

In addition to our accomplished team of executives and industry-leading board of directors, Kardigan launches with $300 million in Series A capital from a strong investor syndicate that …

linkedin.com

$300
OFF

Kardigan - LinkedIn

2 weeks from now

In addition to our accomplished team of executives and industry-leading board of directors, Kardigan launches with $300 million in Series A capital from a strong investor syndicate that …

linkedin.com

$300
OFF

Kardigan Raises $300M Series A - Citybiz

2 weeks from now

Jan 14, 2025 · Kardigan, a San Francisco, CA-based heart health company modernizing cardiovascular drug development, raised USD300M in Series A funding. The round was led by …

citybiz.co

$300
OFF

MyoKardia Alumni Launch Kardigan With $300M To Tackle Heart …

2 weeks from now

Jan 10, 2025 · The team’s initial focus at Kardigan will be on disease opportunities and patient segments that are resistant or poorly managed on current therapies, including primary and …

biospace.com

$300
OFF

Kardigan, A Cardiovascular Drug Development Company Is …

2 weeks from now

Jan 22, 2025 · Kardigan, based in South San Francisco was launched earlier this month with a $300 million Series A round (1). Kardigan was founded by the industry cardiovascular veterans …

biotechhcfinancetrans.blogspot.com

$300000000
OFF

Founder Lodge | Kardigan Raises $300,000,000 At Series A On 2025 …

2 weeks from now

14/01/2025 Series A $300,000,000 Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond …

founderlodge.com

$300
OFF

Kardigan Raises $300m For Cardio Work, And Other Financings

2 weeks from now

Jan 31, 2025 · Kardigan makes its debut with a team of ex-MyoKardia execs and a $300m war chest, with a string of other biotechs also raising funds this week.

pharmaphorum.com

FAQs about Kardigan Launches with Industry-Leading Team - citybiz.co Coupon?

What is a kardigan series a?

A new company is making its debut with a series A sum that’s sure to make hearts race. Launching with $300 million in hand, Kardigan plans to develop parallel treatments to prevent and cure cardiovascular diseases so that they’re no longer the leading cause of death worldwide, the company announced in a Jan. 10 release. ...

How much money does kardigan invest in?

In addition to our accomplished team of executives and industry-leading board of directors, Kardigan launches with $300 million in Series A capital from a strong investor syndicate that includes Perceptive Advisors, ARCH Venture Partners, and Sequoia Heritage. ...

What does kardigan do?

By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the underlying cardiovascular disease pathophysiology to get patients closer to the cures they deserve. For more information about Kardigan, please visit kardigan.bio. ...

Where can I find more information about kardigan?

For more information about Kardigan, please visit kardigan.bio. If you are interested in joining our passionate and driven team with deep cardiovascular, biotechnology and operational expertise, please visit kardigan.bio or the careers tab of this page. ...

Is kardigan hiring?

Kardigan is #hiring! We are looking for driven individuals who share our entrepreneurial spirit and passion for patients to join our San Francisco and Princeton, NJ teams. No matter the role, our people are part of a community united by our resolve to transform #CVD through groundbreaking therapies. Interested in learning more? ...

How does kardigan's R&D platform work?

Kardigan’s R&D platform uses a proprietary set of cardiac-specific tools to understand the mechanisms behind its therapeutic candidates as well as the individual responses patients have to treatments, the company said. ...